Maribao, Kim Estila L.

HRN: 25-79-04  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/14/2025
CEFTRIAXONE 1G (VIAL)
12/14/2025
12/20/2025
IV DRIP
1.5g
OD
PCAP
Checking Final Appropriateness 

Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Intervention



Type of Intervention done:

                    

           


Acceptance: